Sankyo Co. Newsletter
-
From Prevention for Daiichi-Sankyo | AstraZeneca
30 Apr 2025 00:17 GMT
… report side effects to Daiichi Sankyo at 1-877-437-7763 … , and Medication Guide.
© 2025 Daiichi Sankyo, Inc. and AstraZeneca.
PP-US …
-
Daiichi Sankyo, AstraZeneca's highly touted ADC Datroway off to 'smooth market launch'
28 Apr 2025 22:23 GMT
… -drug conjugate launched by Daiichi Sankyo and AstraZeneca, Datroway has a …
-
Daiichi Sankyo says production boost in US will help cushion tariff impact
28 Apr 2025 17:40 GMT
Daiichi Sankyo has reiterated that its earlier …
-
Daiichi Sankyo Company, Limited (DSKYF) FY2024 Earnings Call Transcript
26 Apr 2025 05:25 GMT
Daiichi Sankyo Company, Limited (OTCPK:DSKYF) FY2024 … would like to begin Daiichi Sankyo's Financial Results Conference … today to attend the Daiichi Sankyo’s financial results briefing. I …
-
AstraZeneca Faces Intensified Probe in China as Tax Evasion Amount Grows
01 May 2025 03:36 GMT
… -developed with Japan’s Daiichi Sankyo Co. Ltd., as part of …
-
AZ backs up threat of manufacturing shift from Europe
30 Apr 2025 19:06 GMT
… a 34% rise in Daiichi Sankyo-partnered Enhertu (trastuzumab deruxtecan) to …
-
Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight
30 Apr 2025 17:00 GMT
… Tianqing Pharmaceutical Group, AstraZeneca, Daiichi Sankyo, Inc., Tyme, Inc., Seagen Inc … , Evgen Pharma, Tyme, Genentech, Daiichi Sankyo, among others. Triple Negative Breast … key TNBC companies including Daiichi Sankyo, OBI Pharma, Astellas Pharma, Pfizer …
-
The future of NSCLC treatment: what’s in store for the therapeutic space?
30 Apr 2025 14:10 GMT
… with Japanese pharma giant Daiichi Sankyo, received the nod from the …
-
Can Immunotherapy Replace Surgery in Some Solid Tumors?
30 Apr 2025 12:18 GMT
… with AbbVie, Amgen, Agenus, Daiichi Sankyo, GSK, Merck, Regeneron, Roche, and …
-
US FDA grants breakthrough device designation to Roche's companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non─small cell lung cancer
30 Apr 2025 05:35 GMT
… benefit from treatment with Daiichi Sankyo and AstraZeneca’s Datroway (datopotamab … conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by … AstraZeneca and Daiichi Sankyo.
The VENTANA TROP2 (EPR20043) RxDx …